Find a Clinical Trial

Find a Clinical Trial

Search by practice name, trial titles, indicators and specific disease types.

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

CA20973L: A Phase 3, Randomized, Open Label Study to Compare Nivolumab plus Concurrent Chemoradiotherapy (CCRT) followed by Nivolumab plus Ipilimumab or Nivolumab plus CCRT Followed by Nivolumab vs CCRT followed by Durvalumab in Previously Untreated, Locally Advanced Non-small Cell Lung Cancer (LA NSCLC)

  • Details

ClinicalTrials.gov ID: NCT04026412
Diagnosis Type: NA
USOR Number: 19088

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 2 Study of Erdafitinib in Subjects With Advanced Solid Tumors and FGFR Gene Alterations (42756493CAN2002)

  • Details

ClinicalTrials.gov ID: NCT04083976
Diagnosis Type: NA
USOR Number: 19092

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 2, Open-Label, 2-Cohort, Multicenter Study of INCB050465, a PI3Kä Inhibitor, in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a BTK Inhibitor (CITADEL-205)- INCB050465-205

  • Details

ClinicalTrials.gov ID: NCT03235544
Diagnosis Type: Non-Hodgkins
USOR Number: 17093

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Myelomas

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

(Amgen 20180015) A Randomized, Open-label, Phase 3 Study Comparing Once-weekly vs Twice-weekly Carfilzomib in Combination with Lenalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (A.R.R.O.W.2).

  • Details

ClinicalTrials.gov ID: NCT03859427
Diagnosis Type: NA
USOR Number: 19036

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

(MO40597) A MULTICENTRIC, OPEN-LABEL, SINGLE ARM STUDY OF OBINUTUZUMAB SHORT DURATION INFUSION (SDI) IN PATIENTS WITH PREVIOUSLY UNTREATED ADVANCED FOLLICULAR LYMPHOMA (PHASE IV STUDY)

  • Details

ClinicalTrials.gov ID: NCT03817853
Diagnosis Type: NA
USOR Number: 18265

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

QBGJ398-302: Phase 3, Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial of Infigratinib for the Adjuvant Treatment of Subjects with Invasive Urothelial Carcinoma with Susceptible FGFR3 Genetic Alterations (PROOF302)

  • Details

ClinicalTrials.gov ID: NCT04197986
Diagnosis Type: NA
USOR Number: 19094

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreak 100) (20170543)

  • Details

ClinicalTrials.gov ID: NCT03600883
Diagnosis Type: NA
USOR Number: 19024

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Colon Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreak 100) (20170543)

  • Details

ClinicalTrials.gov ID: NCT03600883
Diagnosis Type: NA
USOR Number: 19024

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Pancreatic Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreak 100) (20170543)

  • Details

ClinicalTrials.gov ID: NCT03600883
Diagnosis Type: NA
USOR Number: 19024

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Endometrial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreak 100) (20170543)

  • Details

ClinicalTrials.gov ID: NCT03600883
Diagnosis Type: NA
USOR Number: 19024

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Solid Tumors

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreak 100) (20170543)

  • Details

ClinicalTrials.gov ID: NCT03600883
Diagnosis Type: NA
USOR Number: 19024

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 1/2, Open-label Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 510 Monotherapy in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation and AMG 510 Combination Therapy in Subjects With Advanced NSCLC With KRAS p.G12C Mutation (CodeBreak 100) (20170543)

  • Details

ClinicalTrials.gov ID: NCT03600883
Diagnosis Type: NA
USOR Number: 19024

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lung Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

Brigatinib-3001- A Phase 3 Randomized Open-label Study of Brigatinib (ALUNBRIG®)Versus Alectinib (ALECENSA®) in Advanced Anaplastic Lymphoma Kinase-Positive Non–Small-Cell Lung Cancer Patients Who Have Progressed on Crizotinib (XALKORI®)

  • Details

ClinicalTrials.gov ID: NCT03596866
Diagnosis Type: NA
USOR Number: 18129

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment with Ibrutinib (BGB-3111-215)

  • Details

ClinicalTrials.gov ID: NCT03206918
Diagnosis Type: NA
USOR Number: 18263

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Leukemia

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 2, Multicenter, Single-arm Study of Zanubrutinib (BGB-3111) in Patients with Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Intolerant of Prior Treatment with Ibrutinib (BGB-3111-215)

  • Details

ClinicalTrials.gov ID: NCT03206918
Diagnosis Type: NA
USOR Number: 18263

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Lymphomas

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

Treatment Patterns, Outcomes, and Patient-Reported Health-Related Quality of Life: A Prospective Disease Registry of Patients with Mantle Cell Lymphoma Treated with Novel Agents (D8220R00004)

  • Details

ClinicalTrials.gov ID: NCT03816683
Diagnosis Type: NA
USOR Number: 18127

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Urothelial Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

Biomarker Study to Identify Subjects with Advanced Urothelial Cancer and Fibroblast Growth Factor Receptor Gene Aberrations (42756493BLC0002)

  • Details

ClinicalTrials.gov ID: NCT03955913
Diagnosis Type: NA
USOR Number: 19032

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Breast Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

STAR: Randomized, double-blind, phase 3 study of tucatinib or placebo in combination with ado-trastuzumab emtansine (T-DM1) for subjects with unresectable locally-advanced or metastatic HER2+ breast cancer (SGNTUC-016)

  • Details

ClinicalTrials.gov ID: NCT03975647
Diagnosis Type: NA
USOR Number: 19054

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Bladder Cancer

Clinical Trial at: Rocky Mountain Cancer Centers - Lakewood

A Phase 3, Randomized, Study of Neoadjuvant Chemotherapy alone versus Neoadjuvant Chemotherapy plus Nivolumab or Nivolumab and BMS-986205, Followed by Continued Post-Surgery Therapy with Nivolumab or Nivolumab and BMS-986205 in Participants with Muscle-Invasive Bladder Cancer (CA017078)

  • Details

ClinicalTrials.gov ID: NCT03661320
Diagnosis Type: NA
USOR Number: 18095

  • Practice Details

11750 W 2nd Place, Med Plaza 1, Suite 150
Lakewood, Colorado 80228
36.50 mi. away
P: (303) 430-2700

More Details View Practice Page

Pages